Authors of a new study found that patients who develop diabetes later in life have a higher risk of cardiovascular disease.
Semaglutide (Wegovy) Receives FDA Label Expansion to Include Cardiovascular Risk Reduction
Diabetes Dialogue: T1D Glycemic Improvement and CRISTAL at ATTD 2024
Endocrinology Month in Review: February 2024
Diabetes Dialogue: FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD
SGLT2 Inhibitor Use Lowers Anemia Risk in Patients with Diabetes, CKD
FDA Clears Dexcom Stelo Sensor, First OTC Glucose Sensor in Agency History